Polyzwitterionic micelles with antimicrobial-conjugation for eradication of drug-resistant bacterial biofilms.


Journal

Colloids and surfaces. B, Biointerfaces
ISSN: 1873-4367
Titre abrégé: Colloids Surf B Biointerfaces
Pays: Netherlands
ID NLM: 9315133

Informations de publication

Date de publication:
Nov 2023
Historique:
received: 19 08 2023
revised: 07 09 2023
accepted: 11 09 2023
medline: 3 11 2023
pubmed: 18 9 2023
entrez: 17 9 2023
Statut: ppublish

Résumé

The presence of bacterial biofilms has presented a significant challenge to human health. This study presents the development of biofilm microenvironment-responsive polymeric micelles as a novel approach to address the challenges posed by bacterial biofilms. These micelles are composed of two key components: a zwitterionic component, inspired by protein isoelectric points, containing balanced quantities of primary amines and carboxylic groups that undergo a positive charge transformation in acidic microenvironments, and a hydrophobic triclosan conjugate capable of releasing triclosan in the presence of bacterial lipases. Through the synergistic combination of pH-responsiveness and lipase-responsiveness, we have significantly improved drug penetration into biofilms and enhanced its efficacy in killing bacteria. With their remarkable drug-loading capacity and the ability to specifically target and eliminate bacteria within biofilms, these zwitterionic polymeric micelles hold great promise as an effective alternative for treating biofilm-associated infections. Their unique properties enable efficient drug delivery and heightened effectiveness against biofilm-related infections.

Identifiants

pubmed: 37717312
pii: S0927-7765(23)00420-4
doi: 10.1016/j.colsurfb.2023.113542
pii:
doi:

Substances chimiques

Micelles 0
Triclosan 4NM5039Y5X
Anti-Bacterial Agents 0
Drug Carriers 0
Anti-Infective Agents 0
Polymers 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

113542

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors have no conflicts of interest to declare.

Auteurs

Yunhong Qian (Y)

The People's Hospital of Yuhuan, Yuhuan, Zhejiang 317600, China; Fushun People's Hospital, Zigong, Sichuan 643200, China.

Xiaoli Hu (X)

Department of Gynecology, the First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China.

Jinhui Wang (J)

The People's Hospital of Yuhuan, Yuhuan, Zhejiang 317600, China.

Yuanfeng Li (Y)

Translational Medicine Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang 325035, China. Electronic address: yuanfengli@wmu.edu.cn.

Yong Liu (Y)

Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang 325001, China. Electronic address: y.liu@ucas.ac.cn.

Lingping Xie (L)

The People's Hospital of Yuhuan, Yuhuan, Zhejiang 317600, China. Electronic address: 627152879@qq.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH